|
Group
|
Telegroup, N = 27
|
P-value
|
Control group, N = 25
|
P-value
|
|---|
| |
BL
|
9 M
|
Mean difference
| |
BL
|
9 M
|
Mean difference
| |
|---|
|
6MWT steps
|
522 ± 113
|
662 ± 86.4
|
140 ± 95.2
|
0.006*
|
553 ± 103
|
601 ± 88.7
|
48.3 ± 85.2
|
0.23
|
|
6MWT distance
|
377 ± 88.0
|
464 ± 60.5
|
87.0 ± 65.7
|
0.006*
|
377 ± 78.0
|
400 ± 72.4
|
23.9 ± 70.3
|
0.23
|
|
FEV1%
|
50.2 ± 15.0
|
52.7 ± 16.7
|
2.5 ± 5.2
|
0.10
|
52.6 ± 17.4
|
52.6 ± 19.8
|
-.07 ± 9.2
|
0.99
|
|
CAT
|
19.0 ± 6.9
|
16.0 ± 5.6
|
−2.9 ± 4.5
|
0.04*
|
17.6 ± 5.0
|
22.0 ± 6.9
|
4.4 ± 5.7
|
0.013*
|
- Characteristics of patient population baseline (BL) compared to 9-month follow-up; data is presented as Mean ± SD; group comparisons of measurements across different Randomization Groups were done using a paired student’s t-test; *statistical significance is set at P ≤ 0.05. 6MWT = 6-minute walk test; FEV1 (%) = Forced Expiratory Volume in one second% predicted; CAT = COPD Assessment Test.
